Literature DB >> 11988409

Serological evidence of endemic waterborne cryptosporidium infections.

Floyd J Frost1, Tim Muller, Gunther F Craun, William B Lockwood, Rebecca L Calderon.   

Abstract

PURPOSE: Cryptosporidium oocysts are commonly detected in surface-derived drinking water, however, the public health significance of these findings is unclear. This study compared the evidence of prior Cryptosporidium infection for people drinking water derived from surface versus ground water sources.
METHODS: This study measured serological responses to two Cryptosporidium antigen groups for blood donors from two midwestern United States cities with different drinking water sources: filtered and chlorinated river water receiving agricultural and domestic sewage upstream versus chlorinated water from an underground aquifer. Initial and nine-month paired serological responses to two Cryptosporidium antigen groups were compared.
RESULTS: Initially, donors from the surface water city had a higher relative prevalence (RP) of a serological response (54% vs. 38%, RP = 1.39 (1.21,1.60)). Donors with a detectable baseline response who resided in the surface water city had a higher relative risk (RR) of an increased intensity of response on the follow-up blood draw (15/17-kDa, 40/100 vs. 11/100, RR = 3.78 (1.89,7.58)), (27-kDa 38/100 vs. 18/100, RR = 2.07 (1.31,3.25)). Donors with no baseline response to the 15/17-kDa marker who resided in the surface water city also had a higher risk of serconversion (38/100 vs. 14/100, RR = 2.63 (1.78,3.91)).
CONCLUSIONS: These rates of both background and drinking water related Cryptosporidium infections are substantially higher than previously estimated, however, the risk of illness from infection may be lower.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988409     DOI: 10.1016/s1047-2797(01)00313-1

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  7 in total

1.  Quality assurance considerations in cryptosporidium antibody tests.

Authors:  Floyd Frost; Tim Muller; Twila Kunde; Gunther Craun
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 2.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

3.  Serological responses to Cryptosporidium-specific antigens in Czech populations with different water sources.

Authors:  F Kozisek; G F Craun; L Cerovska; P Pumann; F Frost; T Muller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

4.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

5.  Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland.

Authors:  Cynthia C McOliver; Hanna B Lemerman; Ellen K Silbergeld; Richard D Moore; Thaddeus K Graczyk
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

6.  Emerging Causes of Traveler's Diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia.

Authors:  Richard Goodgame
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

7.  Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000.

Authors:  Stella Goh; Mark Reacher; David P Casemore; Neville Q Verlander; Rachel Chalmers; Margaret Knowles; Joy Williams; Keith Osborn; Sarah Richards
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.